Literature DB >> 19582395

Decreased surfactant phosphatidylcholine synthesis in neonates with congenital diaphragmatic hernia during extracorporeal membrane oxygenation.

Daphne J Janssen1, Luc J Zimmermann, Paola Cogo, Aaron Hamvas, Kajsa Bohlin, Ingrid H Luijendijk, Darcos Wattimena, Virgilio P Carnielli, Dick Tibboel.   

Abstract

PURPOSE: Congenital diaphragmatic hernia (CDH) may result in severe respiratory insufficiency with a high morbidity. The role of a disturbed surfactant metabolism in the pathogenesis of CDH is unclear. We therefore studied endogenous surfactant metabolism in the most severe CDH patients who required extracorporeal membrane oxygenation (ECMO).
METHODS: Eleven neonates with CDH who required ECMO and ten ventilated neonates without significant lung disease received a 24-h infusion of the stable isotope [U-(13)C] glucose. The (13)C-incorporation into palmitic acid in surfactant phosphatidylcholine (PC) isolated from serial tracheal aspirates was measured. Mean PC concentration in epithelial lining fluid (ELF) was measured during the first 4 days of the study.
RESULTS: Fractional surfactant PC synthesis was decreased in CDH-ECMO patients compared to controls (2.4 +/- 0.33 vs. 8.0 +/- 2.4%/day, p = 0.04). The control group had a higher maximal enrichment (0.18 +/- 0.03 vs. 0.09 +/- 0.02 APE, p = 0.04) and reached this maximal enrichment earlier (46.7 +/- 3.0 vs. 69.4 +/- 6.6 h, p = 0.004) compared to the CDH-ECMO group, which reflects higher and faster precursor incorporation in the control group. Surfactant PC concentration in ELF was similar in both groups.
CONCLUSION: These results show that CDH patients who require ECMO have a decreased surfactant PC synthesis, which may be part of the pathogenesis of severe pulmonary insufficiency and has a negative impact on weaning from ECMO.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19582395      PMCID: PMC2749174          DOI: 10.1007/s00134-009-1564-7

Source DB:  PubMed          Journal:  Intensive Care Med        ISSN: 0342-4642            Impact factor:   17.440


  35 in total

1.  Impaired spreading of surfactant phospholipids in the lungs of newborn rats with pulmonary hypoplasia as a model of congenital diaphragmatic hernia induced by nitrofen.

Authors:  T Utsuki; K Hashizume; M Iwamori
Journal:  Biochim Biophys Acta       Date:  2001-03-30

2.  Pulmonary barotrauma in congenital diaphragmatic hernia: a clinicopathological correlation.

Authors:  Y Sakurai; K Azarow; E Cutz; A Messineo; R Pearl; D Bohn
Journal:  J Pediatr Surg       Date:  1999-12       Impact factor: 2.545

3.  Treatment with exogenous surfactant stimulates endogenous surfactant synthesis in premature infants with respiratory distress syndrome.

Authors:  J E Bunt; V P Carnielli; D J Janssen; J L Wattimena; W C Hop; P J Sauer; L J Zimmermann
Journal:  Crit Care Med       Date:  2000-10       Impact factor: 7.598

4.  Expression of intrapulmonary surfactant apoprotein-A in autopsied lungs: comparative study of cases with or without pulmonary hypoplasia.

Authors:  H Minowa; Y Takahashi; C Kawaguchi; T Sadou; N Konishi; T Nishikubo; A Yoshioka
Journal:  Pediatr Res       Date:  2000-11       Impact factor: 3.756

5.  Congenital diaphragmatic hernia in 120 infants treated consecutively with permissive hypercapnea/spontaneous respiration/elective repair.

Authors:  Judd Boloker; David A Bateman; Jen-Tien Wung; Charles J h Stolar
Journal:  J Pediatr Surg       Date:  2002-03       Impact factor: 2.545

6.  Surfactant phosphatidylcholine pool size in human neonates with congenital diaphragmatic hernia requiring ECMO.

Authors:  Daphne J M T Janssen; Dick Tibboel; Virgilio P Carnielli; Esther van Emmen; Ingrid H T Luijendijk; J L Darcos Wattimena; Luc J I Zimmermann
Journal:  J Pediatr       Date:  2003-03       Impact factor: 4.406

7.  Endogenous surfactant metabolism in newborn infants with and without respiratory failure.

Authors:  Kajsa Bohlin; Assaad Merchak; Kimberly Spence; Bruce W Patterson; Aaron Hamvas
Journal:  Pediatr Res       Date:  2003-05-07       Impact factor: 3.756

8.  Endogenous pulmonary surfactant metabolism is not affected by mode of ventilation in premature infants with respiratory distress syndrome.

Authors:  Assaad Merchak; Daphne J Janssen; Kajsa Bohlin; Bruce W Patterson; Luc J Zimmermann; Virgilio P Carnielli; Aaron Hamvas
Journal:  J Pediatr       Date:  2002-06       Impact factor: 4.406

9.  Surfactant synthesis and kinetics in infants with congenital diaphragmatic hernia.

Authors:  Paola E Cogo; Luc J I Zimmermann; Federica Rosso; Francesca Tormena; Piergiorgio Gamba; Giovanna Verlato; Aldo Baritussio; Virgilio P Carnielli
Journal:  Am J Respir Crit Care Med       Date:  2002-07-15       Impact factor: 21.405

10.  Surfactant levels in congenital diaphragmatic hernia.

Authors:  Marcus Davey
Journal:  PLoS Med       Date:  2007-07-31       Impact factor: 11.069

View more
  3 in total

1.  Proteomic profiling of tracheal fluid in an ovine model of congenital diaphragmatic hernia and fetal tracheal occlusion.

Authors:  Jose Luis Peiro; Marc Oria; Emrah Aydin; Rashika Joshi; Nichole Cabanas; Ronny Schmidt; Christoph Schroeder; Mario Marotta; Brian M Varisco
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2018-09-27       Impact factor: 5.464

Review 2.  Year in review in Intensive Care Medicine 2009. Part III: mechanical ventilation, acute lung injury and respiratory distress syndrome, pediatrics, ethics, and miscellanea.

Authors:  Massimo Antonelli; Elie Azoulay; Marc Bonten; Jean Chastre; Giuseppe Citerio; Giorgio Conti; Daniel De Backer; François Lemaire; Herwig Gerlach; Goran Hedenstierna; Michael Joannidis; Duncan Macrae; Jordi Mancebo; Salvatore M Maggiore; Alexandre Mebazaa; Jean-Charles Preiser; Jerôme Pugin; Jan Wernerman; Haibo Zhang
Journal:  Intensive Care Med       Date:  2010-02-23       Impact factor: 17.440

Review 3.  Exogenous surfactant therapy in 2013: what is next? Who, when and how should we treat newborn infants in the future?

Authors:  Emmanuel Lopez; Géraldine Gascoin; Cyril Flamant; Mona Merhi; Pierre Tourneux; Olivier Baud
Journal:  BMC Pediatr       Date:  2013-10-10       Impact factor: 2.125

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.